Old TB vaccine shows promise in taming type 1 diabetes
NCT ID NCT02081326
First seen Dec 16, 2025 · Last updated May 25, 2026 · Updated 26 times
Summary
This study tests whether repeated doses of the BCG vaccine (originally for tuberculosis) can lower blood sugar levels in adults with long-standing type 1 diabetes. About 150 participants will receive either BCG or a placebo over 5 years, with researchers tracking changes in HbA1c and insulin use. The goal is to improve glucose control without relying on the pancreas, by boosting the body's own sugar transport system.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Immunobiology Labs CNY 149
Charlestown, Massachusetts, 02129, United States
Conditions
Explore the condition pages connected to this study.